These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 29564857)

  • 1. [Ideal Medication-Readiness Cutoff Score for Initiating Antiviral Therapy in HIV Patients].
    Hsieh CY; Lai YY; Chen YC; Lin CC; Liu LF; Ko NY
    Hu Li Za Zhi; 2018 Apr; 65(2):54-63. PubMed ID: 29564857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating Measures of Pre-ART Adherence Readiness Through Associations with ART Adherence in the Early Months of Treatment.
    Azhar GS; Schneider S; Hoffman R; Gordon K; Ramirez D; Wagner G
    AIDS Behav; 2020 Feb; 24(2):648-654. PubMed ID: 31650358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of the HIV Medication Readiness Scale.
    Balfour L; Tasca GA; Kowal J; Corace K; Cooper CL; Angel JB; Garber G; Macpherson PA; Cameron DW
    Assessment; 2007 Dec; 14(4):408-16. PubMed ID: 17986658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.
    Siegfried N; Uthman OA; Rutherford GW
    Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD008272. PubMed ID: 20238364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simplified clinical algorithm for identifying patients eligible for same-day HIV treatment initiation (SLATE): Results from an individually randomized trial in South Africa and Kenya.
    Rosen S; Maskew M; Larson BA; Brennan AT; Tsikhutsu I; Fox MP; Vezi L; Bii M; Venter WDF
    PLoS Med; 2019 Sep; 16(9):e1002912. PubMed ID: 31525187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to On-Time ART Drug Pick-Up and Its Association with CD4 Changes and Clinical Outcomes Amongst HIV Infected Adults on First-Line Antiretroviral Therapy in Nigerian Hospitals.
    Anoje C; Agu KA; Oladele EA; Badru T; Adedokun O; Oqua D; Khamofu H; Adebayo O; Torpey K; Chabikuli ON
    AIDS Behav; 2017 Feb; 21(2):386-392. PubMed ID: 27388161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors informing HIV providers' decisions to start antiretroviral therapy for young people living with behaviorally acquired HIV.
    Lee L; Rand CS; Ellen JM; Agwu AL
    J Adolesc Health; 2014 Sep; 55(3):358-65. PubMed ID: 24794054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.
    Gupta SB; Pujari SN; Joshi SR; Patel AK;
    J Assoc Physicians India; 2006 Jan; 54():57-74. PubMed ID: 16649742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.
    Alvarez-Uria G; Naik PK; Pakam R; Midde M
    Glob Health Action; 2013 Sep; 6():21682. PubMed ID: 24028937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Delays in the Initiation of Antiretroviral Therapy for Clinically Eligible HIV-Infected Patients in Houston, Texas: The Providers' Report Card.
    Mgbere O; Rodriguez-Barradas M; Vigil KJ; McNeese M; Tabassam F; Barahmani N; Wang J; Arafat R; Essien EJ
    J Int Assoc Provid AIDS Care; 2018; 17():2325958218774042. PubMed ID: 29745311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of HIV Care Clinic Attendance and Adherence to Antiretroviral Therapy Among Pregnant and Breastfeeding Women Living With HIV in the Context of Option B+ in Zimbabwe.
    Erlwanger AS; Joseph J; Gotora T; Muzunze B; Orne-Gliemann J; Mukungunugwa S; Farley T; Mangwiro AZ
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S198-S206. PubMed ID: 28498190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation?
    Newell ML; Patel D; Goetghebuer T; Thorne C;
    J Infect Dis; 2006 Apr; 193(7):954-62. PubMed ID: 16518757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of a stage of change instrument in assessing medication adherence in indigent patients with HIV infection.
    Rathbun RC; Farmer KC; Lockhart SM; Stephens JR
    Ann Pharmacother; 2007 Feb; 41(2):208-14. PubMed ID: 17213294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian setting.
    Nolan S; Milloy MJ; Zhang R; Kerr T; Hogg RS; Montaner JS; Wood E
    AIDS Care; 2011 Aug; 23(8):980-7. PubMed ID: 21480010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reasons for delayed antiretroviral therapy (ART) initiation in the era of early ART initiation guidelines: a retrospective service evaluation.
    Lee MJ; Venturelli S; McKenna W; Teh J; Negedu O; Florman KE; Musbahi E; Bailey AC; Mackie NE; Fox J; Fidler S
    Int J STD AIDS; 2019 Mar; 30(4):415-418. PubMed ID: 30621548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral treatment initiation among HIV-positive participants in the Bangkok men who have sex with men cohort study, 2006-2016.
    Wimonsate W; Sriporn A; Pattanasin S; Varangrat A; Promda N; Sukwicha W; Holtz TH; Ungsedhapand C; Chitwarakorn A; Hickey AC; Dunne EF
    Int J STD AIDS; 2021 Jul; 32(8):687-693. PubMed ID: 33629883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
    Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
    AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How soon after HIV seroconversion is antiretroviral therapy initiated? The UK Register of HIV Seroconverters Steering Committee.
    AIDS; 1999 Jul; 13(10):1241-7. PubMed ID: 10416529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research on the treatment effects and drug resistances of long-term second-line antiretroviral therapy among HIV-infected patients from Henan Province in China.
    Chen J; Zhang M; Shang M; Yang W; Wang Z; Shang H
    BMC Infect Dis; 2018 Nov; 18(1):571. PubMed ID: 30442114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.